Marsh & McLennan Companies, Inc. (MRSH) Stock Price Today
Aura AI Summary
Key Stats
- $81.96BMarket Cap
- 1,968,419Volume
- FinancialsSector
- $207.0252W High
- $157.3252W Low
- 108 DaysTypical Hold Time
- $102.64BEnterprise Value
- 2.31%Div Yield
- -Trading Activity
Track Marsh & McLennan Companies, Inc. (MRSH) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Marsh & McLennan Companies, Inc. has traded between a low of $157.32 and a high of $207.02, highlighting its annual price range. Buy and sell Marsh & McLennan Companies, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Marsh & McLennan Companies, Inc.
Marsh & McLennan Companies Inc is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (management and economic consultancy).
Most Recent News
MMR vaccines now available at 530+ CVS locations in New York amid measles outbreak
In response to a measles outbreak and statewide emergency in New York, CVS Health is offering measles-mumps-rubella (MMR) vaccinations at over 530 CVS Pharmacy locations and MinuteClinic sites across the state. The MMR vaccine is crucial to prevent t...

Best Eli Lilly stock buys were during crises, not at hype peaks of Mounjaro and Zepbound drug approvals.
Eli Lilly's most profitable stock entry points were during less hyped events like the 2008 ImClone acquisition and the 2014 Trulicity approval, yielding returns over 2,000%. In contrast, buying at the peaks of hype around blockbuster drugs Mounjaro a...

Deutsche Bank maintains 'sell' on Travis Perkins amid weak UK construction demand.
Deutsche Bank has reaffirmed its 'sell' rating on Travis Perkins with a target price of 550p, slightly below the current 572.5p share price. The bank highlights ongoing weakness in the UK construction market, noting a 10% drop in brick deliveries in ...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.